Tyrphostin AG 538

CAS No. 133550-18-2

Tyrphostin AG 538( —— )

Catalog No. M35935 CAS No. 133550-18-2

Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC 0 : for 400 nM) that is potent, cell-permeable, reversible, and competitive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 152 Get Quote
5MG 235 Get Quote
10MG 353 Get Quote
25MG 601 Get Quote
50MG 821 Get Quote
100MG 1062 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tyrphostin AG 538
  • Note
    Research use only, not for human use.
  • Brief Description
    Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC 0 : for 400 nM) that is potent, cell-permeable, reversible, and competitive.
  • Description
    AG 538 is a potent, competitive inhibitor of IGF-1 receptor kinase, with an IC50 of 400 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    IGF-1R
  • Recptor
    IGF-1R
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133550-18-2
  • Formula Weight
    297.26
  • Molecular Formula
    C16H11NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(/C(=C/C1=CC(O)=C(O)C=C1)/C#N)(=O)C2=CC(O)=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. G Blum, et al. Substrate Competitive Inhibitors of IGF-1 Receptor Kinase. Biochemistry. 2000 Dec 26;39(51):15705-12.?
molnova catalog
related products
  • GSK1904529A

    GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM.

  • CTLA-4 inhibitor

    CTLA-4 inhibitor is a potent CTLA-4 inhibitor.

  • Insulin efsitora alf...

    Insulin efsitora alfa (LY-3209590) is a selective insulin receptor (IR) agonist and fusion protein that combines a novel single-chain insulin variant with the structural domain of human IgG Fc for the study of type 2 diabetes.